We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cambridge Cognition Holdings Plc | LSE:COG | London | Ordinary Share | GB00B8DV9647 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.20 | 2.18% | 56.20 | 54.00 | 55.00 | 54.50 | 54.50 | 54.50 | 21,504 | 16:35:07 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 12.61M | -409k | -0.0117 | -46.58 | 18.99M |
TIDMCOG
RNS Number : 2667G
Cambridge Cognition Holdings PLC
25 May 2017
25(th) May 2017
Cambridge Cognition Holdings Plc
('Cambridge Cognition' or the 'Company')
Result of AGM & Board Change
The neuroscience company Cambridge Cognition Holdings plc (AIM: COG), which develops and markets products and near patient technologies for cognitive assessment in clinical trials and healthcare applications held its Annual General Meeting today at 10.00am at the registered office of the Company, Tunbridge Court, Tunbridge Lane, Bottisham, Cambridge, CB25 9TU. All resolutions were duly passed.
During the meeting the Company announced that Dr. Andrew (Andy) Blackwell, formerly CSO and currently Non-Executive Director, will be standing down from the board with effect from 1(st) July 2017.
Non-Executive Chairman at Cambridge Cognition, Michael Lewis commented: "We would like to thank Andy for his major contribution to the development of Cambridge Cognition. He has played a key role in shaping the scientific foundation and reputation of the Company and in building a new science leadership team. The Company is entering a new phase in its development as new wearable and digital health technologies are brought to market and we will seek a new Board member to continue Andy's work in this next stage in the Company's development."
Enquiries:
Cambridge Cognition Holdings plc Steven Powell, Chief Executive Tel: 01223 810 Officer 700 Noah Konig, Director of Product press@camcog.com Marketing and Communications finnCap Ltd (Nomad & Joint Broker) Tel: 020 7220 0500 Geoff Nash / Simon Hicks (Corporate Finance) Alice Lane (Corporate Broking) Dowgate Capital Stockbrokers Tel: 020 3903 Limited (Joint Broker) 7715 David Poutney/ James Serjeant (Corporate Broking)
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGMMGZKFKLGNZM
(END) Dow Jones Newswires
May 25, 2017 09:22 ET (13:22 GMT)
1 Year Cambridge Cognition Chart |
1 Month Cambridge Cognition Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions